Post job

Celerus Diagnostics's revenue is $1.0 million.

What is Celerus Diagnostics's revenue?

Celerus Diagnostics's annual revenue is $1.0M. Zippia's data science team found the following key financial metrics about Celerus Diagnostics after extensive research and analysis.
  • Celerus Diagnostics has 30 employees, and the revenue per employee ratio is $33,333.
  • Celerus Diagnostics peak revenue was $1.0M in 2024.

On this page

Peak revenue
$1.0M (2024)
Company peak revenue
Revenue / employee
$33,333
Company revenue / employee

Zippi applies for you, and finds you a job.

Floating question marks illustration
Peak revenue
$1.0M (2024)
Company peak revenue
Revenue / employee
$33,333
Company revenue / employee

Celerus Diagnostics financing

Celerus Diagnostics received early financing of $2.7M on 2005-12-02.

SeriesRound sizeDate
Series A$2.7M12/2005
Series B$9M08/2006
Series C$5M04/2009

Celerus Diagnostics investors

InvestorsSecurity type
Vector Laboratories IncSeries B

Celerus Diagnostics competitors

Celerus Diagnostics's top competitor, Aralez Pharmaceuticals, earned an annual revenue of $105.9M.

Celerus Diagnostics's smallest competitor is TransEngen with revenue of $1.2M last year.

Company nameAverage salaryRevenueEmployee sizeJob openings
Nextremity Solutions-$4.7M39-
Gish Biomedical-$7.5M100-
Swissray International-$5.9M50-
TransEngen-$1.2M30-
Aralez Pharmaceuticals-$105.9M100-
Genesis Pharmaceutical-$1.5M50-
Phonic Ear A/S-$2.9M30-

Celerus Diagnostics revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Celerus Diagnostics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Celerus Diagnostics. The employee data is based on information from people who have self-reported their past or current employments at Celerus Diagnostics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Celerus Diagnostics. The data presented on this page does not represent the view of Celerus Diagnostics and its employees or that of Zippia.

Celerus Diagnostics may also be known as or be related to CELERUS DIAGNOSTICS INC, Celerus Diagnostics and Celerus Diagnostics, Inc.